about
Tissue distribution of the opioid receptor-like (ORL1) receptorNavigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples.Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells.Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor.Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysisInvolvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice.GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.Extracellular signal-regulated kinase (ERK) inhibition does not prevent the development or expression of tolerance to and dependence on morphine in the mouseOpioid-modulating properties of the neuropeptide FF system.Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.Solubilization and reconstitution of the mu-opioid receptor expressed in human neuronal SH-SY5Y and CHO cells.Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization.Modulation of extracellular signal-regulated kinase (ERK) activity by acute and chronic opioid treatment in neuronal and glial cell lines.Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor.Description of the low-affinity interaction between nociceptin and the second extracellular loop of its receptor by fluorescence and NMR spectroscopies.Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice.Pharmacological characterization of the mouse NPFF2 receptor.Nitroglycerin inhibits the development of morphine tolerance and dependence in rats.Direct identification of a peptide binding region in the opioid receptor-like 1 receptor by photoaffinity labeling with [Bpa(10),Tyr(14)]nociceptin.Protein degradation, as with protein synthesis, is required during not only long-term spatial memory consolidation but also reconsolidation.Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.Central Apelin Controls Glucose Homeostasis via a Nitric Oxide-Dependent Pathway in MiceCharacterization of a new radioiodinated probe for the alpha2C adrenoceptor in the mouse brainA high-affinity, radioiodinatable neuropeptide FF analogue incorporating a photolabile p-(4-hydroxybenzoyl)phenylalanineAgonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists
P50
Q28139226-0609870F-B79A-43C3-8D5D-D325F041E6EEQ30931131-FAB1AFA9-9F0D-466F-8654-C7745C2B2031Q33993802-C33EB2BD-BF8B-43A9-B8E2-EDFF82564EF5Q34317508-56F2C5EA-1A27-4F30-AC62-DE75FD6DBCD7Q34634103-0C90CB9C-71D0-4F04-8E71-203310251620Q35578528-3B7F1908-35A7-43B9-9B3F-CB560897E6B7Q35708164-D0CE149D-FE08-4F99-8ABC-22002F137445Q35806909-0F8B8339-D39B-4069-AB8A-D5E2D90769F2Q35921655-7E6F0F29-E4EB-4950-9A2D-0863278CB96DQ36294544-6352714C-4465-4E97-AA59-50FF17FF6C3AQ37783966-FAB44D6A-33AE-49B8-BAB5-56A74964AE2FQ38658021-E097F77F-9CC1-4AC4-AB97-3ADA72BBF91DQ39019855-3607BFE1-2514-40EC-8C76-71E66FD5F370Q39730858-5CF3B509-E925-424C-9EE5-E9E8FB545F8CQ39973481-F7F09FAD-8B79-435F-85F0-C5AD43EB19EDQ40420719-9239F904-965B-4A7F-B775-38347AF7F37FQ40520226-1DE6A2BC-E818-4DCE-9ECF-B903AF866CC9Q40677688-A6CDC3C1-C2F5-4DBE-91E4-80AF057C3E59Q42664321-1078CD01-7F79-49AE-9DE9-E93CE0BE7E5DQ43017426-1F6158C8-DE38-4718-9243-115185A47110Q43234312-124B74B1-CFB6-4A89-BF7E-B032E8F8403EQ44288232-2CFBADB6-FD81-4D27-B804-F9322F362D30Q44332139-1C955E5B-AFF9-4BEB-B69D-3E9FAB7E4A0BQ46512120-97CD553C-050D-45F8-A624-E9432C6D6954Q50462945-62A9504A-ECC7-4554-A58B-E4D60FC0F205Q60843013-92C71D44-F162-40F5-9CEA-7102E76EDEB8Q73194918-00FB14D3-1AE7-445A-9486-6715431CA3D2Q87419157-31E1BE54-21AA-4494-88DB-5DC54E093985Q92635639-136CCAFD-2575-4439-A8AF-15999F0D7975
P50
description
researcher ORCID ID = 0000-0002-7675-3493
@en
name
Lionel Moulédous
@ast
Lionel Moulédous
@en
Lionel Moulédous
@es
Lionel Moulédous
@nl
type
label
Lionel Moulédous
@ast
Lionel Moulédous
@en
Lionel Moulédous
@es
Lionel Moulédous
@nl
prefLabel
Lionel Moulédous
@ast
Lionel Moulédous
@en
Lionel Moulédous
@es
Lionel Moulédous
@nl
P1153
6603207664
P21
P31
P496
0000-0002-7675-3493